Literature DB >> 14764936

Evaluation of different conditions for ligating dumbbell-shaped oligonucleotides.

Hiroshi Yamagiwa1, Mark E Bolander, Gobinda Sarkar.   

Abstract

We tested three different standard ligation conditions (37 degrees C for 30 min, 16 degrees C for 24 h, and 4 degrees C for 48 h) to generate dumbbell-shaped oligonucleotides (ODNs) as transcription factor decoys for SOX9 and alphaA-crystallin binding protein 1 (CRYBP1), which are positive and negative transcriptional regulators for type II collagen expression in chondrocytes. Decoy ODN for CRYBP1 was successfully produced as a "dumbbell" by all three conditions. A small amount of decoy ODN for SOX9, however, remained unligated under all three ligation conditions. Ligation at 4 degrees C for 48 h appeared to be the least desirable for SOX9 ODN. Transfection experiments with the SOX9 ODN ligated in different conditions and a luciferase-based reporter system also supports this conclusion. In general, shorter incubation time produced more acceptable results for this ODN than incubation for a longer time. These data suggest that different ligation conditions should be tested prior to creating dumbbell-shaped ODNs for transfection experiments.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14764936     DOI: 10.1385/MB:26:2:111

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  9 in total

1.  Sequence-specific inhibition of a transcription factor by circular dumbbell DNA oligonucleotides.

Authors:  T Hosoya; H Takeuchi; Y Kanesaka; H Yamakawa; N Miyano-Kurosaki; K Takai; N Yamamoto; H Takaku
Journal:  FEBS Lett       Date:  1999-11-19       Impact factor: 4.124

2.  Binding of hairpin and dumbbell DNA to transcription factors.

Authors:  B C Chu; L E Orgel
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

3.  A zinc finger transcription factor, alphaA-crystallin binding protein 1, is a negative regulator of the chondrocyte-specific enhancer of the alpha1(II) collagen gene.

Authors:  K Tanaka; Y Matsumoto; F Nakatani; Y Iwamoto; Y Yamada
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

4.  Sequential staining of short oligonucleotides in polyacrylamide gels with ethidium bromide and methylene blue.

Authors:  C S Lim; C A Hunt
Journal:  Biotechniques       Date:  1994-10       Impact factor: 1.993

Review 5.  Oligonucleotides as transcription factor decoys.

Authors:  Y S Cho-Chung; Y G Park; Y N Lee
Journal:  Curr Opin Mol Ther       Date:  1999-06

6.  An 18-base-pair sequence in the mouse proalpha1(II) collagen gene is sufficient for expression in cartilage and binds nuclear proteins that are selectively expressed in chondrocytes.

Authors:  V Lefebvre; G Zhou; K Mukhopadhyay; C N Smith; Z Zhang; H Eberspaecher; X Zhou; S Sinha; S N Maity; B de Crombrugghe
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

7.  SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene.

Authors:  V Lefebvre; W Huang; V R Harley; P N Goodfellow; B de Crombrugghe
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

8.  Ex vivo regulation of specific gene expression by nanomolar concentration of double-stranded dumbbell oligonucleotides.

Authors:  C Clusel; E Ugarte; N Enjolras; M Vasseur; M Blumenfeld
Journal:  Nucleic Acids Res       Date:  1993-07-25       Impact factor: 16.971

9.  Chondrogenic differentiation of clonal mouse embryonic cell line ATDC5 in vitro: differentiation-dependent gene expression of parathyroid hormone (PTH)/PTH-related peptide receptor.

Authors:  C Shukunami; C Shigeno; T Atsumi; K Ishizeki; F Suzuki; Y Hiraki
Journal:  J Cell Biol       Date:  1996-04       Impact factor: 10.539

  9 in total
  1 in total

1.  Oligonucleotide decoy mimicking alphaA-crystallin-binding protein 1 binding site on mouse Col2a1 enhancer stimulates transcription from the adjacent Col2a1 promoter in chondrogenic ATDC5 cell.

Authors:  Hiroshi Yamagiwa; Yoshihiko Yamada; Mark E Bolander; Gobinda Sarkar
Journal:  Mol Biotechnol       Date:  2004-09       Impact factor: 2.695

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.